Pursuing claims-based data on what happens to patients taking their drugs, pharma companies have been striking pacts with payers and PBMs. Now, a heavyweight in the research field, IMS Health, has ...
IMS Health says it's restating those numbers, citing missing data. Although specifics aren't yet available, analysts say they're expecting the revised figures to show prescription growth, rather than ...
Introduction. Efforts to limit the commercial use of data on physician prescribing could have broad implications for regulatory programs that promote drug safety. At issue are a series of laws pursued ...
Oct. 13 (Reuters) - IMS Health, which provides prescription data and other services to the pharmaceutical industry, said it is revising estimates of the number of prescriptions written in late ...
When the fundamentals of master data management are handled properly in an end-to-end solution from a trusted partner like IMS Health, a company benefits from: • Improved data quality: With a ...
Once again, a drug-related legal battle stands to change the business landscape. The Supreme Court may hear a pharma case--namely, a court fight over data-mining--that could revamp the way all sorts ...
The company's intangible assets--its proprietary data sets, technology, expertise, and reputation--place Quintiles IMS well ahead of its closest competitors. IMS Health's legacy business compiles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback